Literature DB >> 8352844

Litonit: evaluation of clinical effectiveness.

V I Kresyn1, V L Aryaev, F I Kostev.   

Abstract

Clinical data are presented on a new anti-alcoholic drug, litonit. A substantial reduction in the pathological addiction to alcohol takes place under the effect of litonit, and a stable aversive reaction to alcohol develops. The new drug is distinguished by its low toxicity, good tolerance, and its failure to cause disorders of the liver and kidneys even after chronic administration.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8352844

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  1 in total

1.  Improving lithium therapeutics by crystal engineering of novel ionic cocrystals.

Authors:  Adam J Smith; Seol-Hee Kim; Naga K Duggirala; Jingji Jin; Lukasz Wojtas; Jared Ehrhart; Brian Giunta; Jun Tan; Michael J Zaworotko; R Douglas Shytle
Journal:  Mol Pharm       Date:  2013-11-18       Impact factor: 4.939

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.